Cancer as an Evolutionary Process: Inherited Risk, Modifiable Risk, and Which Screens Have Mortality Evidence

A clinical account of where cancer can actually be interrupted — germline syndromes that change management now, the metabolic and inflammatory contribution, and the hard line between screens with mortality data and screens with detection data only.